Trademark: 74464818
Status Date
Friday, April 3, 2020
Registration Number
2012226
Registration Date
Tuesday, October 29, 1996
Filing Date
Thursday, December 2, 1993
Published for Opposition
Tuesday, May 9, 1995
Cancellation Date
Friday, April 3, 2020
5 prescription pharmaceutical, namely, a radiolabelled compound, which is administered intravenously to aid in the diagnosis of Parkinson's disease
Apr 3, 2020
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Jun 2, 2010
Automatic Update Of Assignment Of Ownership
Mar 18, 2009
Automatic Update Of Assignment Of Ownership
Jun 15, 2007
Registered And Renewed (First Renewal - 10 Yrs)
Jun 15, 2007
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
May 23, 2007
Assigned To Paralegal
Apr 25, 2007
Registered - Combined Section 8 (10-Yr) & Sec. 9 Filed
Apr 25, 2007
Teas Section 8 & 9 Received
Apr 25, 2007
Automatic Update Of Assignment Of Ownership
Jun 23, 2006
Case File In Ticrs
Aug 28, 2003
Teas Change Of Correspondence Received
Jul 25, 2003
Registered - Sec. 8 (6-Yr) Accepted
Apr 28, 2003
Registered - Sec. 8 (6-Yr) Filed
Apr 28, 2003
Paper Received
Oct 29, 1996
Registered-Principal Register
Aug 20, 1996
Allowed Principal Register - Sou Accepted
May 22, 1996
Statement Of Use Processing Complete
Aug 9, 1996
Extension 2 Granted
May 22, 1996
Use Amendment Filed
May 22, 1996
Extension 2 Filed
Mar 5, 1996
Extension 1 Granted
Jan 3, 1996
Extension 1 Filed
Aug 1, 1995
Noa Mailed - Sou Required From Applicant
May 9, 1995
Published For Opposition
Apr 7, 1995
Notice Of Publication
Dec 13, 1994
Approved For Pub - Principal Register
Nov 18, 1994
Correspondence Received In Law Office
Jun 14, 1994
Non-Final Action Mailed
Apr 28, 1994
Assigned To Examiner
Apr 26, 1994
Assigned To Examiner
Apr 25, 1994
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
